Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Top Companion Anim Med ; 32(1): 31-35, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28750788

RESUMO

Avascular necrosis of the femoral head is a developmental disturbance that generally affects young dogs of small breeds and produces ischemic necrosis of the femoral head resulting in an incongruous and malformed joint. The most common treatment is the excisional arthroplasty of the head and femoral neck. The aim of this study is to describe the treatment of avascular necrosis in a Yorkshire dog using intra-articular injections of autologous platelet concentrate. Evaluations were made at 0, 15, 30, 60, and 120 days of treatment, describing the following parameters: clinical gait analysis, perimetry, goniometry, and radiographic evaluations. The results obtained in this case suggest that the autologous platelet concentrate may be an alternative for the treatment of avascular necrosis of the femoral head in dogs.


Assuntos
Plaquetas , Doenças do Cão/terapia , Necrose da Cabeça do Fêmur/veterinária , Animais , Cães , Cabeça do Fêmur/patologia , Necrose da Cabeça do Fêmur/terapia
2.
BMC Vet Res ; 9: 77, 2013 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-23587176

RESUMO

BACKGROUND: The aim of this study was to use transmission electron microscopy to describe the ultrastructural characteristics of clots obtained from canine and feline platelet concentrates (PC) that had been activated with calcium gluconate (CG) or CG plus batroxobin (CGB). Platelets from fibrin clots were classified according their morphological changes. The area of the intercellular space (µm2), the area of the fibrin fibers (µm2), and the width of the fibrin fibers (µm) were determined for the dog clots. The platelet area (µm2), the area of fibrin fibers (µm2), the ratio of the minor and major axes of platelets, the ratio of the major and minor axes of platelets, and the number of α-granules found within platelets were measured for the cat clots. RESULTS: Cat platelets displayed full activation. Dog platelets displayed lysis with loss of normal architecture. In both species, a statistically significant difference was found (P < 0.01) between the fibrin fiber measurements in the PC clots activated with CG and CGB. CONCLUSIONS: The findings suggest that activation with CG caused platelet alpha granules to release their contents. In cats, fibrin production was greater when the PC was activated with CG. In dogs, activation with CG produced thick fibrin fibers.


Assuntos
Batroxobina/farmacologia , Coagulação Sanguínea/efeitos dos fármacos , Plaquetas/ultraestrutura , Gluconato de Cálcio/farmacologia , Fibrina/ultraestrutura , Fibrinolíticos/farmacologia , Animais , Batroxobina/administração & dosagem , Plaquetas/efeitos dos fármacos , Gluconato de Cálcio/administração & dosagem , Gatos/sangue , Cães/sangue , Quimioterapia Combinada , Espaço Extracelular/efeitos dos fármacos , Fibrina/efeitos dos fármacos , Fibrinolíticos/administração & dosagem , Masculino , Microscopia Eletrônica de Transmissão/veterinária , Trombose/veterinária
3.
BMC Vet Res ; 8: 212, 2012 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-23131192

RESUMO

BACKGROUND: There are not reported regarding the protocols for obtaining platelet concentrates (PC) in cats for medical purposes. The objectives of this study were: 1) to describe a manual method for producing two kinds of PC in cats (PC-A and PC-B), 2) to describe the cellular population of the PC, 3) to measure and compare the effect of calcium gluconate (CG) and bovine thrombin (BT) on the temporal release of transforming growth factor beta 1 (TGF-ß1) and platelet-derived growth factor type BB (PDGF-BB) at 3 and 12 hours post-activation and 4) to establish correlations between the cellular population of both PCs and the concentration of growth factors (GF). Blood samples were taken from 16 cats for complete blood count, plasma collection and PC preparation. The PC were arbitrarily divided into two fractions, specifically, PC-A (lower fraction) and PC-B (upper fraction). RESULTS: The platelet counts were significantly different (P<0.05) between the PC and whole blood but not between the PC fractions. The TGF-ß1 concentration efficiencies for PC-A and PC-B activated with CG were 42.86% and 46.54%, and activated with BT were 42.88% and 54.64%, respectively. The PDGF-BB concentration efficiencies for PC-A and PC-B activated with CG were 61.36% and 60.61%, and activated with BT were 65.64% and 72.12%, respectively. The temporal release of GFs showed no statistically significant difference (P>0.05) between the activating substances at the time or for any PC fraction. CONCLUSIONS: Whatever the activation means, these preparations of cat PC provide significant concentrations of platelets and GFs for possible clinical or experimental use.


Assuntos
Plaquetas/metabolismo , Gluconato de Cálcio/farmacologia , Gatos , Proteínas Proto-Oncogênicas c-sis/metabolismo , Trombina/farmacologia , Fator de Crescimento Transformador beta1/metabolismo , Animais , Becaplermina , Coleta de Amostras Sanguíneas , Bovinos , Feminino , Masculino , Proteínas Proto-Oncogênicas c-sis/genética , Fator de Crescimento Transformador beta1/genética
4.
BMC Vet Res ; 8: 121, 2012 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-22830991

RESUMO

BACKGROUND: The clinical use of autologous platelet concentrates (also known as platelet-rich plasma) on the field of regenerative therapy, in the last decade has been the subject of several studies especially in equine medicine and surgery. The objectives of this study was: 1) to describe and compare the cellular population in whole blood, lower fraction (A) and upper fraction (B) of platelet concentrates, 2) to measure and compare the transforming growth factor beta 1 (TGF-ß1) concentration in plasma and both platelet concentrates after be activated with calcium gluconate or batroxobin plus calcium gluconate and, 3) to determine correlations between cell counts in platelet concentrates and concentrations of TGF-ß1. Blood samples were taken from 16 dogs for complete blood count, plasma collection and platelet concentrates preparation. The platelet concentrates (PC) were arbitrarily divided into two fractions, specifically, PC-A (lower fraction) and PC-B (upper fraction). The Platelet concentrates were analyzed by hemogram. After activated with calcium gluconate or batroxobin plus calcium gluconate, TGF-ß1 concentration was determined in supernatants of platelet concentrates and plasma. RESULTS: There were differences statistically significant (P < 0.05) for the platelet count and leukocyte count and TGF-ß1 concentration between whole blood, plasma and both platelet concentrates. A significant correlation was found between the number of platelets in both platelet concentrates and TGF-ß1 concentration. Platelet collection efficiency was 46.34% and 28.16% for PC-A and PC-B, respectively. TGF-ß1 concentration efficiency for PC activated with calcium gluconate was 47.75% and 31.77%, for PC-A and PC-B, respectively. PC activated with batroxobin plus CG showed 46.87% and 32.24% for PC-A and PC-B, respectively. CONCLUSIONS: The methodology used in this study allows the concentration of a number of platelets and TGF-ß1 that might be acceptable for a biological effect for clinical or experimental use as a regenerative therapy in dogs.


Assuntos
Batroxobina/farmacologia , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Gluconato de Cálcio/farmacologia , Cães , Fator de Crescimento Transformador beta/metabolismo , Animais , Regulação da Expressão Gênica/efeitos dos fármacos , Fator de Crescimento Transformador beta/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...